Nutritional composition intended for specific gastro-intestinal maturation in premature mammals
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61K-047/00
A61K-038/00
A01N-037/18
출원번호
US-0936446
(2002-03-04)
우선권정보
EP-0200753 (1999-03-12)
국제출원번호
PCT/EP00/01744
(2000-03-01)
국제공개번호
WO00/54603
(2000-09-21)
발명자
/ 주소
Garcia-Rodenas, Clara L.
Finot, Paul-Andre
Maire, Jean-Claude
Ballevre, Olivier
Net-Hughes, Anne
Haschke, Ferdinand
출원인 / 주소
Nestec S.A.
대리인 / 주소
Bell, Boyd & Lloyd LLC
인용정보
피인용 횟수 :
13인용 특허 :
3
초록
A nutritional enteral composition intended for favoring the growth and maturation of non-mature gastro-intestinal tracts of young mammals, which contains as a protein source a mixture of dietary protein hydrolysates and intact proteins being partly in the form of bioactive peptides.
대표청구항▼
A nutritional enteral composition intended for favoring the growth and maturation of non-mature gastro-intestinal tracts of young mammals, which contains as a protein source a mixture of dietary protein hydrolysates and intact proteins being partly in the form of bioactive peptides. and antigens, bi
A nutritional enteral composition intended for favoring the growth and maturation of non-mature gastro-intestinal tracts of young mammals, which contains as a protein source a mixture of dietary protein hydrolysates and intact proteins being partly in the form of bioactive peptides. and antigens, biological response modifiers, alpha-interferon, platinum coordination complexes, anthracenedione, substituted-ureas, methylhydrazine derivatives, adrenocortical suppressants, adrenocorticosteroids, progestins, estrogens, anti-estrogens, androgens, anti-androgens, solvents that destroy cancer cells causing the release of cancer antigens, and mixtures thereof. 3. A method for the treatment of cancer through the enhancement of the immune system to attack cancerous tumor cells and the inhibition of capillary growth to tumors through the simultaneous use of immunostimulators and anti-cancer agents to kill said cells, said method comprising (i) the administration of an effective amount of urushiol in a pharmaceutically acceptable carrier together with, (ii) the co-administration of one or more secondary immunostimulators selected from the group consisting of cytokines, tumor-associated proteins and antigens, tumor vaccines, lipopolysaccharides, Bacillus Calmette-Gurin, immunoglobulin, alpha-interferon, interleukin-2, levamisole, isoprinosine, and mixtures thereof together with, (iii) the co-administration of an anti-cancer agent selected from the group consisting essentially of adriamycin, surgery, ultra-sound, photo-reactive compounds, anthracyclines, nitrogen mustards, ethyleneamines, methylmelamines, alkyl-sulfonates, nitrosoureas, triazenes, folic acid analogs, pyrimidine analogs, purine analogs and related inhibitors, vinca alkaloids, epipodophyllotoxins, antibiotics, biological response modifiers, platinum coordination complexes, anthracenedione, substituted-ureas, methylhydrazine derivatives, adrenocortical suppressants, adrenocorticosteroids, progestins, estrogens, anti-estrogens, androgens, anti-androgens, solvents that destroy cancer cells causing the release of cancer antigens, and mixtures thereof.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (3)
Lee Jin S. (Houston TX) Blick Mark (Houston TX), Bioactive EGF peptides for promotion of tissue regeneration and cancer therapy.
DeWille Normanella T. (Upper Arlington OH) Mazer Terrence B. (Reynoldsbury OH) Snowden Gregory A. (Pickerington OH), Enteral nutritional with protein system containing soy protein hydrolysate and intact protein.
Petschow, Bryon W.; McMahon, Robert J.; Gibson, Glenn R.; Rastall, Robert A.; Gemmell, Renia; Saarela, Maria; Aura, Anna-Marja, Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.